PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Wheaton Precious Metals Corp. (WPM)
96.701.20 (1.26%)
95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.84%
Positive revenue growth while FSM is negative. John Neff might see a notable competitive edge here.
-5.28%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-0.35%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-0.35%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-86.91%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-86.84%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-86.84%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.19%
Share change of 0.19% while FSM is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.01%
Slight or no buyback while FSM is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
17.11%
Dividend growth of 17.11% while FSM is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
8.12%
Positive OCF growth while FSM is negative. John Neff would see this as a clear operational advantage vs. the competitor.
127.02%
Positive FCF growth while FSM is negative. John Neff would see a strong competitive edge in net cash generation.
196.24%
10Y CAGR of 196.24% while FSM is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
7.88%
5Y revenue/share CAGR under 50% of FSM's 36.65%. Michael Burry would suspect a significant competitive gap or product weakness.
24.99%
3Y revenue/share CAGR at 50-75% of FSM's 40.29%. Martin Whitman would question if the firm lags behind competitor innovations.
192.99%
OCF/share CAGR of 192.99% while FSM is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
-14.53%
Negative 5Y OCF/share CAGR while FSM is at 167.79%. Joel Greenblatt would question the firm’s operational model or cost structure.
13.51%
3Y OCF/share CAGR under 50% of FSM's 35.90%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-77.12%
Negative 10Y net income/share CAGR while FSM is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-93.99%
Negative 5Y net income/share CAGR while FSM is 309.51%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-90.63%
Negative 3Y CAGR while FSM is 128.67%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
285.20%
Equity/share CAGR of 285.20% while FSM is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
49.04%
5Y equity/share CAGR 1.25-1.5x FSM's 40.42%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
18.79%
Below 50% of FSM's 50.69%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
-42.97%
Negative 5Y dividend/share CAGR while FSM stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-42.97%
Negative near-term dividend growth while FSM invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-20.14%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-100.00%
Inventory is declining while FSM stands at 10.38%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-2.73%
Negative asset growth while FSM invests at 3.60%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.66%
We have a declining book value while FSM shows 4.21%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-11.30%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-60.99%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.